Cilo Cybin revives JSE listing plans
Cilo Cybin Holdings Ltd, a Johannesburg-based medical cannabis company, announced its IPO, after securing $3 million in funding from ALPS Global Holding Berhad. The firm aims to acquire and invest in ‘viable assets’ operating in the biotech, bio-hacking or pharmaceutical sectors. Joining CNBC Africa for more is Gabriel Theron, CEO, Cilo Cybin Pharmaceutical.
Source: CNBC Africa
